File(s) not publicly available
Regulation of Innovative Pharmaceuticals in the EU and the US
report
posted on 2023-06-08, 00:57 authored by John Abraham, Courtney DavisCombining theories of citizenship with documentary plus interview field methods, the proposed research will compare the regulation of innovative pharmaceuticals in the EU and the US from 1995 to 2000. It will do this: (i) by focusing on, and explaining, the inconsistencies in approvals/withdrawals of the same innovative pharmaceuticals between these European and American regulatory systems; and (ii) by considering how these regulatory systems can respond to recent, and potential future, challenges, such as the cost-effectiveness and appropriate therapeutic use of some new innovative pharmaceuticals, which command extensive medical and public demand, and the possible introduction of greater transparency and comparative effectiveness into regulatory agencies risk-benefit assessments of innovative pharmaceuticals
History
Publication status
- Published
Publisher
Economic and Social Research CouncilPublisher URL
Department affiliated with
- Sociology and Criminology Publications
Full text available
- No
Peer reviewed?
- No
Legacy Posted Date
2012-02-06Usage metrics
Categories
No categories selectedKeywords
Licence
Exports
RefWorks
BibTeX
Ref. manager
Endnote
DataCite
NLM
DC